30 trial slots on Asia's first kidney cancer histotripsy treatment

The Li Ka Shing Foundation is offering 30 trial slots through three private hospitals to treat kidney cancer through histotripsy -- a non-invasive treatment technology that uses focused ultrasound waves to destroy tumours at the cellular level.

Earlier, the foundation donated histotripsy machines to the HKU and CUHK's Faculty of Medicine, and Hong Kong Sanatorium & Hospital to treat liver tumors and pancreatic cancer.

More than 400 patients have been treated with histotripsy in the past two years.

The latest scheme makes Hong Kong the first city in Asia to conduct clinical trials using the technology to treat kidney cancer patients.